Search results for: 'group purchase organization'

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

Volkswagen's (VW) concession of corporate malfeasance in circumventing Environmental Protection Agency (EPA) testing in the US has sent the global automotive industry into a tailspin. This research service examines the fallout from the emission scandal and its impact on the Volkswagen group, as well as the wider automotive ecosystem.

09 Jul 2018  |  Europe  |  Market Research

Competitive Profiling of Key Aftermarket Buying Groups and Distributors in the EU5, 2017

Consolidation in Europe and Slowdown in Replacement Demand will Drive Local Buying Groups and Distributors to Look to Foreign Markets for Business Expansion

Infographics

×

Key Issues Addressed Key Benefits

The European automotive aftermarket parts distribution is witnessing a rapid growth. Europe is home to some of the leading Original Equipment Suppliers (OES) that are continuously on the lookout for buying groups and distributors that align with the philosophy of the company. Frost & Sullivan segments the automotive distribution ecosystem into tw...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outc...

The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry focus on increasing the availability of donor organs and improving post-transplant outcomes post-transplant. Pre- and post-transplant diagnostics are us...

Artificial organs are support devices that are either attached to the human body or implanted in the human body to restore the function of an ailing organ or to completely replace a native organ. Artificial organs can be segmented into 7 main categories, that is, cochlear implants, artificial heart, artificial liver, artificial pancreas, artificial...

Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in t...

Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...